Abnormal Uterine Bleeding
From the Journals
Two-drug combo should be first-line standard of care in advanced endometrial cancer
Survival outcomes for the combination paclitaxel-carboplatin were similar to those with paclitaxel, doxorubicin, and cisplatin but with lower...
From the Journals
Menstrual irregularity appears to be predictor of early death
Cardiovascular disease and smoking increase risk.
Clinical Review
2020 Update on abnormal uterine bleeding
The evidence base on management strategies for AUB continues to grow, and recent studies suggest that therapy can be tailored...
Expert Commentary
How effective is elagolix treatment in women with fibroids and HMB?
Elagolix with hormonal add-back therapy (estradiol/norethindrone) was effective: 87.9% of participants who received...
Clinical Review
Evidence-based management of early pregnancy loss
Expectant management, medication management, and uterine aspiration are safe, effective treatment options for early pregnancy...
Conference Coverage
BMD preserved with investigational drug for uterine fibroid bleeding
Two phase 3, randomized trials in women with uterine fibroids and heavy menstrual bleeding enrolled almost 800 women.
Expert Commentary
In the management of cesarean scar defects, is there a superior surgical method for treatment?
According to this meta-analysis, which compared the data on laparoscopic, hysteroscopic, vaginal, and combined laparoscopic and...
Clinical Review
The role of hysteroscopy in diagnosing endometrial cancer
Certain hysteroscopic findings correlate with the likelihood of endometrial carcinoma—and the absence of pathology. Here is a breakdown of...
Clinical Review
Medical management of abnormal uterine bleeding in reproductive-age women
Appropriate clinical evaluation, laboratory assessment, and management can make the difference for many women with AUB, and avoid...
Master Class
Transcervical ablation of symptomatic uterine fibroids under US guidance
Master Class
Treating uterine fibroids